Comprehensive efforts to increase adherence to statin therapy
Alexander VonbankDepartment of Medicine and Cardiology, Academic Teaching Hospital and VIVIT Institute Carinagasse 47, 6800 Feldkirch, AustriaStefan AgewallOslo University Hospital Ullevål and Institute of Clinical Sciences, University of Oslo, Oslo, NorwayKeld Per KjeldsenDepartment of Health Science and Technology, The Faculty of Medicine, Aalborg University, Aalborg, DenmarkBasil S. LewisLady Davis Carmel Medical Center, The Ruth and Bruce Rappaport School of Medicine of the Technion (Israel Institute of Technology), Haifa, IsraelChristian Torp‐PedersenHealth Science and Technology, Aalborg University, Niels Jernes Vej 12, A5-208, 9220 Aalborg, DenmarkClaudio CeconiUniversity Hospital of Ferrara, U.O. Cardiologia, Post Degree School in Cardiology, Heart Failure and Cardiovascular Prevention Unit, Via Aldo Moro 8, 44124 Cona, Ferrara, ItalyChristian Funck‐BrentanoINSERM, CIC-1421 and UMR ICAN 1166, AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, Sorbonne Universités, UPMC Univ Paris, 06, Faculty of Medicine, F-75013 Paris, FranceJuan Carlos KaskiCardiovascular Sciences Research Centre at St George's, University of London, Cranmer Terrace, London SW17 0RE, Great BritainAlexander NiessnerDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, AustriaJuan TamargoDepartment of Pharmacology, School of Medicine, Universidad Complutense, Madrid, SpainThomas WaltherDepartment of Obstetrics, Center for Perinatal Medicine, University of Leipzig, Leipzig, GermanySven WaßmannDepartment of Cardiology, Isar Heart Center, Isarklinikum, Sonnenstr. 24-26, 80331 Munich, GermanyGiuseppe RosanoHarald SchmidtChristoph H. SaelyDepartment of Medicine and Cardiology, Academic Teaching Hospital and VIVIT Institute Carinagasse 47, 6800 Feldkirch, AustriaHeinz DrexelCollege of Medicine, Drexel University, Philadelphia, PA, USA
2016en
ABI
Аннотация
There is compelling evidence that statin therapy improves cardiovascular morbidity and mortality. Unfortunately, statin adherence is far from optimal regarding initiation, execution and persistence of treatment over time.26 Poor adherence to statin therapy is associated with a significantly increased risk of cardiovascular events and mortality. Evidence-based steps to improve adherence are available and should be taken in order to improve patient outcomes. Reinforcing statin adherence appears to have at least as strong beneficial effects as introducing a new drug.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 3Использованных источников: 0